| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 28 | +60.71% | -0.88% | +0.42% | -1.30% | -2.12% | — |
| 14d | 28 | +35.71% | +1.61% | +0.24% | +1.36% | -5.80% | — |
| 30d | 28 | +53.57% | -7.23% | -0.94% | -6.29% | -8.69% | — |
| 60d | 28 | +39.29% | -9.26% | +0.69% | -9.94% | -12.39% | — |
| 90d | 28 | +35.71% | -4.91% | +3.29% | -3.24% | -3.20% | — |
| 180d | 28(4 pending) | +41.67% | -3.21% | +5.74% | -8.76% | -4.85% | — |
| 1y | 28(8 pending) | +55.00% | -7.60% | +14.63% | -22.23% | -24.05% | — |
| 2y | 28(10 pending) | +38.89% | -29.85% | +28.36% | -58.20% | -63.52% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 831,978 | $5.00 | $4.16M | 8,153,107 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 2,000,000 | $5.00 | $10.00M | 6,207,982 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,084,012 | $5.00 | $5.42M | 10,622,957 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,084,010 | $5.00 | $5.42M | 10,622,928 | Feb 27, 2026 | Mar 2, 2026 ↗ | View → |
| NUVL NUVALENT, INC. | SALE | 371,287 | $95.45 | $35.44M | 8,299,225 | Nov 24, 2025 | Nov 24, 2025 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 3,387,539 | $3.20 | $10.84M | 9,538,945 | Jul 31, 2025 | Aug 4, 2025 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 2,599,932 | $3.20 | $8.32M | 7,321,129 | Jul 31, 2025 | Aug 4, 2025 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 3,387,529 | $3.20 | $10.84M | 9,538,918 | Jul 31, 2025 | Aug 4, 2025 ↗ | View → |
| NUVL NUVALENT, INC. | SALE | 1,000,000 | $97.75 | $97.75M | 8,670,512 | Oct 22, 2024 | Oct 24, 2024 ↗ | View → |
| BCAX BICARA THERAPEUTICS INC. | SALE | 7,973,325 | — | — | 0 | Sep 17, 2024 | Sep 17, 2024 ↗ | View → |
| BCAX BICARA THERAPEUTICS INC. | PURCHASE | 35,000 | $18.00 | $630.0K | 897,587 | Sep 17, 2024 | Sep 17, 2024 ↗ | View → |
| BCAX BICARA THERAPEUTICS INC. | PURCHASE | 862,587 | — | — | 862,587 | Sep 17, 2024 | Sep 17, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 114,906 | $10.70 | $1.23M | 11,528,863 | Mar 12, 2024 | Mar 12, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 94,567 | $10.92 | $1.03M | 11,731,809 | Mar 11, 2024 | Mar 12, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 88,040 | $11.13 | $979.9K | 11,643,769 | Mar 11, 2024 | Mar 12, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 47,992 | $10.92 | $524.1K | 11,830,871 | Mar 8, 2024 | Mar 12, 2024 ↗ | View → |
| AHCO ADAPTHEALTH CORP. | SALE | 4,495 | $11.03 | $49.6K | 11,826,376 | Mar 8, 2024 | Mar 12, 2024 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,430,206 | $8.74 | $12.50M | 6,151,406 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,430,206 | $8.74 | $12.50M | 6,151,389 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| LRMR LARIMAR THERAPEUTICS, INC. | PURCHASE | 1,430,205 | $8.74 | $12.50M | 4,207,982 | Feb 16, 2024 | Feb 16, 2024 ↗ | View → |
| NUVL NUVALENT, INC. | PURCHASE | 650,000 | $33.50 | $21.77M | 650,000 | Nov 3, 2022 | Nov 7, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 268,480 | — | — | 268,480 | May 10, 2022 | May 10, 2022 ↗ | View → |
| PEPG PEPGEN INC. | SALE | 273,313 | — | — | 0 | May 10, 2022 | May 10, 2022 ↗ | View → |
| PEPG PEPGEN INC. | PURCHASE | 208,333 | $12.00 | $2.50M | 476,813 | May 10, 2022 | May 10, 2022 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | SALE | 85,113 | — | — | 0 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | SALE | 40 | — | — | 0 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 85,113 | — | — | 85,113 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | SALE | 14,887 | — | — | 85,113 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 40 | — | — | 40 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 50,000 | $1,000.00 | $50.00M | 58,945 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 625,000 | — | — | 625,000 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | PURCHASE | 3,177,543 | — | — | 3,177,543 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| TOI ONCOLOGY INSTITUTE, INC. | SALE | 707,960 | — | — | 40 | Nov 12, 2021 | Nov 16, 2021 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 756,472 | — | — | 756,472 | Oct 26, 2021 | Oct 28, 2021 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | PURCHASE | 387,500 | $16.00 | $6.20M | 1,143,972 | Oct 26, 2021 | Oct 28, 2021 ↗ | View → |
| XLO XILIO THERAPEUTICS, INC. | SALE | 7,186,489 | — | — | 0 | Oct 26, 2021 | Oct 28, 2021 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASE | 1,752,787 | — | — | 1,752,787 | May 4, 2021 | May 4, 2021 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASE | 800,000 | $16.00 | $12.80M | 2,552,787 | May 4, 2021 | May 4, 2021 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | SALE | 15,195,094 | — | — | 0 | May 4, 2021 | May 4, 2021 ↗ | View → |
| TERN TERNS PHARMACEUTICALS, INC. | PURCHASE | 1,717,033 | — | — | 1,717,033 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |
| TERN TERNS PHARMACEUTICALS, INC. | SALE | 1,717,033 | — | — | 0 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |
| TERN TERNS PHARMACEUTICALS, INC. | PURCHASE | 665,000 | $17.00 | $11.30M | 2,382,033 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |
| ANNX ANNEXON, INC. | SALE | 4,043,032 | — | — | 0 | Jul 28, 2020 | Jul 28, 2020 ↗ | View → |
| ANNX ANNEXON, INC. | SALE | 4,043,031 | — | — | 0 | Jul 28, 2020 | Jul 28, 2020 ↗ | View → |
| ANNX ANNEXON, INC. | PURCHASE | 350,000 | $17.00 | $5.95M | 808,914 | Jul 28, 2020 | Jul 28, 2020 ↗ | View → |
| ANNX ANNEXON, INC. | PURCHASE | 458,914 | — | — | 458,914 | Jul 28, 2020 | Jul 28, 2020 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASE | 500,000 | $18.00 | $9.00M | 1,209,936 | Jul 14, 2020 | Jul 14, 2020 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASE | 709,936 | — | — | 709,936 | Jul 14, 2020 | Jul 14, 2020 ↗ | View → |
| NKTX NKARTA, INC. | SALE | 2,626,767 | — | — | 0 | Jul 14, 2020 | Jul 14, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | PURCHASE | 997,589 | — | — | 997,589 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | PURCHASE | 498,795 | — | — | 498,795 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | PURCHASE | 300,000 | $17.00 | $5.10M | 798,795 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | SALE | 997,589 | — | — | 0 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | PURCHASE | 300,000 | $17.00 | $5.10M | 1,297,589 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| RVMD REVOLUTION MEDICINES, INC. | SALE | 498,795 | — | — | 0 | Feb 18, 2020 | Feb 18, 2020 ↗ | View → |
| SDGR SCHRODINGER, INC. | PURCHASE | 250,000 | $17.00 | $4.25M | 250,000 | Feb 10, 2020 | Feb 10, 2020 ↗ | View → |
| SDGR SCHRODINGER, INC. | PURCHASE | 1,346,167 | — | — | 1,346,167 | Feb 10, 2020 | Feb 10, 2020 ↗ | View → |
| SDGR SCHRODINGER, INC. | SALE | 10,063,061 | — | — | 0 | Feb 10, 2020 | Feb 10, 2020 ↗ | View → |
| BDTX BLACK DIAMOND THERAPEUTICS, INC. | PURCHASE | 400,000 | $19.00 | $7.60M | 778,790 | Feb 3, 2020 | Feb 3, 2020 ↗ | View → |
| BDTX BLACK DIAMOND THERAPEUTICS, INC. | PURCHASE | 378,790 | — | — | 378,790 | Feb 3, 2020 | Feb 3, 2020 ↗ | View → |
| BDTX BLACK DIAMOND THERAPEUTICS, INC. | SALE | 1,142,361 | — | — | 0 | Feb 3, 2020 | Feb 3, 2020 ↗ | View → |